Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 14;11(7):e0159233.
doi: 10.1371/journal.pone.0159233. eCollection 2016.

Performance Evaluation of NIPT in Detection of Chromosomal Copy Number Variants Using Low-Coverage Whole-Genome Sequencing of Plasma DNA

Affiliations
Free PMC article

Performance Evaluation of NIPT in Detection of Chromosomal Copy Number Variants Using Low-Coverage Whole-Genome Sequencing of Plasma DNA

Hongtai Liu et al. PLoS One. .
Free PMC article

Abstract

Objectives: The aim of this study was to assess the performance of noninvasively prenatal testing (NIPT) for fetal copy number variants (CNVs) in clinical samples, using a whole-genome sequencing method.

Method: A total of 919 archived maternal plasma samples with karyotyping/microarray results, including 33 CNVs samples and 886 normal samples from September 1, 2011 to May 31, 2013, were enrolled in this study. The samples were randomly rearranged and blindly sequenced by low-coverage (about 7M reads) whole-genome sequencing of plasma DNA. Fetal CNVs were detected by Fetal Copy-number Analysis through Maternal Plasma Sequencing (FCAPS) to compare to the karyotyping/microarray results. Sensitivity, specificity and were evaluated.

Results: 33 samples with deletions/duplications ranging from 1 to 129 Mb were detected with the consistent CNV size and location to karyotyping/microarray results in the study. Ten false positive results and two false negative results were obtained. The sensitivity and specificity of detection deletions/duplications were 84.21% and 98.42%, respectively.

Conclusion: Whole-genome sequencing-based NIPT has high performance in detecting genome-wide CNVs, in particular >10Mb CNVs using the current FCAPS algorithm. It is possible to implement the current method in NIPT to prenatally screening for fetal CNVs.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Examples of FCAPS results and amniotic fluid confirmation of two cases (LMQ155 and ZNY162) with CNVs<10Mb.
A-C, (A) FCAPS result, (B) amniotic fluid sequencing result and (C) karyotyping result of sample LMQ155, which contained a 1.3Mb microduplication on chromosome 13; D-F, FCAPS result (D), amniotic fluid sequencing result (E), and karyotyping result (F) of ZNY162, which contained a 8.7Mb deletion on chromosome 10.
Fig 2
Fig 2. False positive results of sample INC6 by FCAPS showing CNV location near to telomere.

Similar articles

Cited by

References

    1. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, et al. Presence of fetal DNA inmaternal plasma and serum. The Lancet. 1997;350(9076):485–7. - PubMed
    1. Minear MA, Lewis C, Pradhan S, Chandrasekharan S. Global perspectives on clinical adoption of NIPT. Prenatal diagnosis. 2015;35(10):959–67. 10.1002/pd.4637 - DOI - PMC - PubMed
    1. Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenatal diagnosis. 2013;33(7):622–9. 10.1002/pd.4139 - DOI - PubMed
    1. Hardisty EE, Vora NL. Advances in genetic prenatal diagnosis and screening. Current Opinion in Pediatrics. 2014;26(6):634–8. 10.1097/MOP.0000000000000145 - DOI - PubMed
    1. Weise A, Mrasek K, Klein E, Mulatinho M, Llerena JC Jr., Hardekopf D, et al. Microdeletion and microduplication syndromes. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 2012;60(5):346–58. - PMC - PubMed

Grants and funding

The work is supported by Science and Technology Plan of Guangdong Province (no. 2013B022000005), the Guangdong Enterprise Key Laboratory of Human Disease Genomics (no. 2011A060906007), and Shenzhen Engineering Laboratory for Birth Defects Screening (no. [2011]861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.